Yj. Jeon et al., Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation, IMMUNOPHARM, 48(2), 2000, pp. 173-183
In the present study, the mechanism by which dexamethasone (DEX) inhibited
IL-1 beta gene expression in bacterial lipopolysaccharide (LPS)-activated R
AW 264.7 cells was investigated. The decrease in LPS-induced IL-1 beta mRNA
expression was demonstrated by quantitative reverse transcription polymera
se chain reaction (RT-PCR). Since the promoter in IL-1 beta gene contains b
inding motifs for NF-kappa B/Rel, AP-1, NF-IL6, and CREB/ATF, which appear
to be important in LPS-mediated IL-1 beta induction, the effects of DEX on
the activation of these transcription factors were examined. Treatment of D
EX to RAW 264.7 cells induced a dose-related inhibition of NF-kappa B/Rel a
nd AP-1 in chloramphenicol acetyltransferase activity, while neither NF-IL6
nor CREB/ATF activation was affected by DEX. Treatment of RAW 264.7 cells
with DEX inhibited DNA binding of NF-kappa B/Rel and AP-1 proteins to their
cognate DNA sites as measured by electrophoretic mobility shift assay (EMS
A). DEX treatment caused a significant reduction in nuclear c-rel, p65, and
p50 protein contents, and these decreases were paralleled by the accumulat
ion of cytoplasmic c-rel, p65, and p50. DEX treatment of RAW 264.7 cells di
d not inhibit the nuclear translocation of c-jun and c-fos. We found that t
he inhibition of IL-1 beta production by DEX is not related to p38, which i
s important in the IL-1 beta induction. These results suggest that DEX may
inhibit IL-1 beta gene expression by a mechanism involving the blocking of
LPS-induced NF-kappa B/Rel and AP-1 activation. (C) 2000 Elsevier Science B
.V. All rights reserved.